Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim J Hagan

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Journal of Pharmacology|November 3, 2009
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristicsLee A Dawson, Christopher J Langmead, Adeshola Dada, et al.
British Journal of Pharmacology|June 19, 2003
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsDavid R Thomas, Sergio Melotto, Mario Massagrande, et al.
Psychopharmacology|June 19, 2004
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsJane Gartlon, Philip Szekeres, Mark Pullen, et al.
Journal of Neuroscience Research|May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophreniaMichael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Journal of Pharmacology|November 3, 2009
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristicsLee A Dawson, Christopher J Langmead, Adeshola Dada, et al.
British Journal of Pharmacology|June 19, 2003
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsDavid R Thomas, Sergio Melotto, Mario Massagrande, et al.
Psychopharmacology|June 19, 2004
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsJane Gartlon, Philip Szekeres, Mark Pullen, et al.
Journal of Neuroscience Research|May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophreniaMichael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.
Pageof 4